Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers
Lab Test

IHC - Epstein Barr virus - EBV-LMP

The Epstein Barr Virus (EBV) is a common virus that can cause infectious mononucleosis, also known as the "kissing disease", and several other diseases. The virus is also associated with certain types of cancers, such as nasopharyngeal carcinoma and certain types of lymphomas. The IHC test for EBV-LMP (Latent Membrane Protein) is a diagnostic test that helps identify the presence of EBV within the cells of a tissue sample. This test is crucial in the diagnosis and management of cancers and other conditions associated with EBV.


  • Test NameIHC - Epstein Barr virus - EBV-LMP
  • Sample TypeTissue
  • Preparations RequiredThere are no specific preparations such as fasting or water restrictions for this test. The test involves a biopsy procedure, the specifics of which will be instructed by the healthcare provider.
  • Report Time3 days

Latent Membrane Protein (LMP) is a protein expressed by the EBV during its latent phase, which can be detected in affected cells. The test uses antibodies that bind to the LMP, allowing pathologists to visualize the presence of EBV in the tissue sample. This forms an essential part of histopathological diagnosis, especially in cases where EBV infection is suspected to be the underlying cause.

Home Sample Collection Process

1
Book your convenient slot
Book your convenient slot
2
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
Reporting of the sample at lab
4
Download Reports
Download Reports
Frequently Asked Questions

The IHC - EBV-LMP test is essential in diagnosing conditions associated with EBV, especially certain types of cancers like nasopharyngeal carcinoma and some lymphomas. The presence of EBV-LMP indicates an ongoing EBV infection, which might be contributing to the disease process.

No, fasting is not required for this test.

This test is typically done when there is a suspicion of an EBV-related condition, especially certain types of cancers. Your healthcare provider will guide you based on your symptoms, clinical history, and preliminary investigations.

The test measures the presence of EBV Latent Membrane Protein (LMP) in the tissue sample. The presence of LMP suggests an ongoing EBV infection in the cells.

The frequency of this test depends on the clinical situation. In most cases, it is done as part of the initial diagnostic process. However, in certain cases, it may be repeated to assess the progress of the disease or the response to treatment.

In a healthy, uninfected tissue, the IHC - EBV-LMP test would not detect the presence of EBV LMP. However, interpretation of results should always be done in conjunction with clinical findings and other diagnostic tests.

The test involves a biopsy procedure, which will be conducted by a healthcare provider. Ensure that you communicate your complete health history, including any medications or supplements you're taking, as some of these may affect the biopsy procedure or test results.

Several factors can affect the levels of EBV-LMP. These include the stage and type of the disease, response to treatment, and the individual's immune response to the EBV infection.

Nonmodifiable factors include genetic predisposition to EBV infection and related diseases, age, and sex. These factors might affect the body's response to EBV and the progression of EBV-related diseases.

Modifiable factors include lifestyle habits that might affect the immune system, such as nutrition, exercise, and stress management. Maintaining a healthy lifestyle can help strengthen the immune system and potentially affect the course of EBV-related diseases.

In case of abnormal test results, you should consult a specialist who is managing your case. This could be a hematologist, oncologist, or infectious disease specialist, depending on the nature of your condition.

The biopsy procedure involves the removal of a small piece of tissue from the body for examination. The specific procedure depends on the location from which the tissue is being taken. You may experience some discomfort, but pain management will be provided as necessary.

As with any procedure, there are some risks associated with a biopsy, including infection, bleeding, and reactions to anesthesia. However, these risks are generally low, and the healthcare provider will take measures to minimize them.

If you are pregnant and need this test, discuss the potential risks and benefits with your healthcare provider. The decision will be based on your specific situation, considering factors like the urgency of the diagnosis and the location of the biopsy.

Yes, the results of this test can assist your healthcare provider in planning your treatment, especially if EBV-associated disease is diagnosed. It can give valuable information about the disease process and help in predicting the course of the disease.

In conclusion, the IHC - EBV-LMP test is an important diagnostic tool in understanding and managing EBV-related diseases, particularly certain types of cancers. The test provides valuable information that can guide clinical decisions and treatment plans. Always consult with your healthcare provider to understand what your test results mean for your health and treatment options.

IHC - Epstein Barr virus - EBV-LMP
₹ 2000
Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet